Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 1;51(7):747-751.
doi: 10.1097/MPA.0000000000002103.

The Use of Vasopressors During Deceased Donor Pancreas Procurement Decreases the Risk of Pancreas Transplant Graft Failure

Affiliations

The Use of Vasopressors During Deceased Donor Pancreas Procurement Decreases the Risk of Pancreas Transplant Graft Failure

Mary Froehlich et al. Pancreas. .

Abstract

Objectives: The objective of this study was to identify the effect of various vasopressors on pancreas graft failure and patient survival.

Methods: A retrospective analysis of the United Network for Organ Sharing database was performed between 2000 and 2019. Patient and graft survival rates were analyzed up to 5 years posttransplant.

Results: The data included 17,348 pancreas transplant recipients: 12,857 simultaneous pancreas-kidney, 1440 pancreas transplant alone, and 3051 pancreas-after-kidney transplant recipients. Use of dopamine during deceased donor procurement increased graft failure by 18% (hazard ratio [HR], 1.18; P < 0.001). Absence of vasopressor caused graft failure to rise by 8% (HR, 1.08; P = 0.09). Dopamine increased the mortality rate by 37% (HR, 1.37; P < 0.001) and the absence of vasopressor increased the mortality rate by 14% (HR, 1.14; P = 0.02). Phenylephrine and norepinephrine reduced the mortality rate by 10% (HR, 0.90; P = 0.05) and 11% (HR, 0.89; P = 0.10), respectively.

Conclusions: The absence of vasopressor use or the use of dopamine is associated with a higher risk of both pancreas transplant graft failure and recipient mortality. The use of phenylephrine and norepinephrine reduces the risk of mortality. This information should guide deceased donor hemodynamic support management in anticipation of pancreas procurement for future transplantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Kelly W, Lillehei R, Merkel F, et al. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery . 1967;61:827–837.
    1. Gruessner A, Sutherland D. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant . 2005;19:433–455.
    1. Giorgakis E, Mathur A, Chakkera H, et al. Solid pancreas transplant: pushing forward. World J Transplant . 2018;8:237–251.
    1. Gruessner AC, Sutherland DER, Gruessner RWG. Pancreas transplantation in the United States: a review. Curr Opin Organ Transplant . 2010;15:93–101.
    1. Chinnakotla S, Majumder K, Sutherland DE. Controversies in pancreas transplantation. Minerva Chir . 2015;70:57–62.

LinkOut - more resources